Regeneron Pharmaceuticals | REGN - PE Price to Earnings

Stock Price
771.94
Daily Change
-15.10 -1.92%
Monthly
1.22%
Yearly
6.70%
Q1 Forecast
755.50

Regeneron Pharmaceuticals reported $18.11 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Agios Pharmaceuticals USD 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen USD 25.31 15.82 Dec/2025
Astellas Pharma JPY 7.31 2.04 Dec/2025
AstraZeneca USD 27.29 5.8 Dec/2025
Biogen USD 14.02 4.63 Dec/2025
BioMarin Pharmaceutical USD 19.24 0.21 Dec/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Gilead Sciences USD 15.63 0.08 Dec/2025
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
Incyte USD 14.84 2.79 Dec/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
J&J USD 23.62 0.86 Dec/2025
Kyowa Hakko Kirin JPY 19.73 4.27 Dec/2025
Merck USD 13.92 5.08 Dec/2025
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 835.47 802.2 Dec/2025
Novartis USD 15.74 0.15 Sep/2025
Novartis USD 16.05 2.92 Sep/2025
Pfizer USD 14.48 5.18 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sanofi EUR 15.75 1.53 Dec/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
Teva Pharmaceutical Industries USD 10.11 1.04 Dec/2025
United Therapeutics USD 15.7 4.24 Sep/2025
Vertex Pharmaceuticals USD 26.15 2.22 Dec/2025